A detailed history of Gamma Investing LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Gamma Investing LLC holds 1,357 shares of NEO stock, worth $23,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,357
Previous 679 99.85%
Holding current value
$23,272
Previous $9.42 Million 112.53%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$13.4 - $17.73 $9,085 - $12,020
678 Added 99.85%
1,357 $20 Million
Q2 2024

Jul 02, 2024

SELL
$13.01 - $15.77 $4,826 - $5,850
-371 Reduced 35.33%
679 $9.42 Million
Q1 2024

Apr 05, 2024

SELL
$14.06 - $16.79 $6,059 - $7,236
-431 Reduced 29.1%
1,050 $16.5 Million
Q4 2023

Feb 01, 2024

BUY
$11.67 - $20.73 $17,283 - $30,701
1,481 New
1,481 $22 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.